New research uses hyperspectral imaging to see nanoparticles in tissue samples

By Deanna Utroske contact

- Last updated on GMT

New research uses hyperspectral imaging to see nanoparticles in tissue samples
Sara Brenner and her colleagues recently published their work in Wiley’s journal of Microscopy Research and Technique, documenting a quicker more cost-effective method to conduct toxicology studies and other nanovisualization work.

Technology like this has vast implications for the cosmetics and personal care industry. “Nanomaterials have been used for decades in the dermatology consumer space, ranging from sunscreens to anti-aging cosmetics to antimicrobial dressings,” ​says co-author Adam Friedman, Associate Professor of Dermatology and Director of Translational Research at the George Washington School of Medicine and Health Sciences, in a SUNY Polytechnic Institute item about the work.

Our ability to dispel concerns regarding safety has been limited due to the constraints of our imaging approaches, which is why the publication of this now validated technique is so important,” ​he adds.  

New and different

Sara Brenner, MD, MPH and researchers from SUNY Polytechnic Institute, George Washington School of Medicine and Health Sciences, and SUNY Stony Brook have hit upon an alternative to electron microscopy.

“The current gold standard for visualization of nanoparticles in tissue samples is electron microscopy, which is highly time- and resource-intensive,” ​says Brenner, Assistant Professor of Nanobioscience and Assistant Vice President for NanoHealth Initiatives at SUNY Poly.

The article, Hyperspectral imaging of nanoparticles in biological samples: Simultaneous visualization and elemental identification, outlines the alternative—how enhanced darkfield microscopy (EDFM) and hyperspectral imaging (HSI) can be used to see nanoparticles distributed in tissue samples.

This technique seems to be valuable in the academic space as well as commercially. “Availability of an alternative, rapid, and cost-effective method would relieve this analytical bottleneck, not only in nanotoxicology, but in many fields where nanoscale visualization is critical,” ​notes Brenner.  

She explains that “the time and cost burdens associated with nanomaterial analysis and characterization in complex media are hindering progress in many research disciplines.”

More to come

The researchers used their new method to document the presence and distribution of nanoparticles; and then substantiated those results with traditional testing methods. “The system has great versatility and high practical utility – we’ve only begun to scratch the surface of what it can do,”​ says Brenner.

Her team is already at work on further research with other nanomaterials and on a variety of exposure scenarios, e.g. occupational and environmental exposure to nanoparticles.  

Related news

Show more

Related products

show more

The first Exposome-Proof Natural Skin Brightener

The first Exposome-Proof Natural Skin Brightener

Symrise | 20-Oct-2017 | Product Brochure

Time has come to take a new look on pigmentation disorders. UV has long been identified as the main cause for aging and darks spots. But recent research...

SymDiol® 68 a smart synergistic protectant

SymDiol® 68 a smart synergistic protectant

Symrise | 09-Oct-2017 | Product Brochure

Today, cosmetic formulators face an increasingly challenging task to protect formulations and at the same time answering consumers’ desires for less preservatives...

AprinnovaSqualaneBrochure-610x343

Neossance® Squalane, Skin Therapy Benefits

APRINNOVA – A joint venture of AMYRIS and NIKKOL Group | 26-Sep-2017 | Clinical Study

Aprinnova is leading a resurgence in Squalane, reducing supply fears while making it attractive to use in mass/value positioned brands. Aprinnova is addressing...

Related suppliers